CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise in preventing leukemia return after transplant
Disease control Recruiting nowThis early-phase study tests the safety and best dose of revumenib, a drug that blocks a protein fueling leukemia growth, in 27 adults and children with specific genetic types of acute leukemia. Participants take revumenib after a stem cell transplant to help keep the cancer from…
Matched conditions: CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New study investigates blood clot risks in kids with leukemia
Knowledge-focused Recruiting nowThis study is for children and young adults (ages 2 to 21.5) with acute lymphoblastic leukemia or lymphoma who are scheduled to receive the chemotherapy drug calaspargase pegol. The goal is to understand how this drug affects the body's ability to form blood clots. Researchers wi…
Matched conditions: CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 04:12 UTC